| Edit |   |
|---|
| Product Name | Temozolomide |
|---|
| Description | DNA methylating, chemotherapeutic agent. Displays antitumor activity against a board spectrum of tumors, including leukemias, lymphomas and solid tumors (IC50 = 5.0 μM for cytotoxicity against mouse TLX5 lymphoma cells). Induces autophagy in malignant glioma cells. Exhibits enhanced activity when used in combination with CHC (Cat No. 5029). Purity 99%. MW (observed): 194.15 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3,4-Dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide. NSC 362856, CCRG 81045 |
|---|
| Gene, Accession, CAS # | CAS: 85622-93-1 |
|---|
| Catalog # | 2706/50 |
|---|
| Price | |
|---|
| Order / More Info | Temozolomide from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 22665268, 23258843, 23284962, 24496381, 25460932 |
|---|